Najla Al Ali
- Hematology top 1%
- Acute Myeloid Leukemia Research 100
- Chronic Myeloid Leukemia Treatments 16
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 46
- Chronic Lymphocytic Leukemia Research 10
- Hemoglobinopathies and Related Disorders 8
-
- Epigenetics and DNA Methylation 8
-
- Hematological disorders and diagnostics 11
-
- Neutropenia and Cancer Infections 9
- Co-authors
- Rami S. KomrokjiEric PadronJeffrey E. LancetAlan F. ListDavid A. SallmanKendra SweetAndrew KuykendallChetasi Talati
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Blood (46 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Najla Al Ali
98 papers receiving 925 citations
Peers
Comparison fields: 5 of 35
- Hematology 854
- Genetics 532
- Pathology and Forensic Medicine 84
- Molecular Biology 306
- Emergency Medicine 43
Countries citing papers authored by Najla Al Ali
This map shows the geographic impact of Najla Al Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Najla Al Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Najla Al Ali more than expected).
Fields of papers citing papers by Najla Al Ali
This network shows the impact of papers produced by Najla Al Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Najla Al Ali. The network helps show where Najla Al Ali may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Najla Al Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 3 | |
| 11 | 2017 | 0 | |
| 12 | 2017 | 6 | |
| 13 | 2017 | 1 | |
| 14 | 2017 | 2 | |
| 15 | 2017 | 2 | |
| 16 | 2017 | 12 | |
| 17 | 2015 | 23 | |
| 18 | 2015 | 2 | |
| 19 | 2015 | 52 | |
| 20 | 2011 | 30 |
About Najla Al Ali
Najla Al Ali is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 112 papers that have together received 930 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (100 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (46 papers), Chronic Myeloid Leukemia Treatments (16 papers), Hematological disorders and diagnostics (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Neutropenia and Cancer Infections (9 papers), Epigenetics and DNA Methylation (8 papers) and Hemoglobinopathies and Related Disorders (8 papers). The work is most often cited by research in Hematology (854 citations), Genetics (532 citations) and Pathology and Forensic Medicine (84 citations). Najla Al Ali has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Rami S. Komrokji, Eric Padron, Jeffrey E. Lancet, Alan F. List, David A. Sallman, Kendra Sweet, Andrew Kuykendall, Chetasi Talati, Onyee Chan and Mikkael A. Sekeres. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.